Biolife Solutions (BLFS) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Biolife Solutions | 1.20 Bn | 1.12 Bn | 17.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09% |
| Dec 31, 2025 | 5.13% |
| Sep 30, 2025 | 1.90% |
| Jun 30, 2025 | -1.55% |
| Mar 31, 2025 | 1.06% |
| Dec 31, 2024 | 7.20% |
| Sep 30, 2024 | 1.25% |
| Jun 30, 2024 | -3.59% |
| Mar 31, 2024 | -1.26% |
| Dec 31, 2023 | 1.70% |
| Sep 30, 2023 | -5.71% |
| Jun 30, 2023 | -1.67% |
| Mar 31, 2023 | -1.67% |
| Dec 31, 2022 | -10.10% |
| Sep 30, 2022 | -1.08% |
| Jun 30, 2022 | -13.97% |
| Mar 31, 2022 | -0.41% |
| Dec 31, 2021 | -2.29% |
| Sep 30, 2021 | 8.18% |
| Jun 30, 2021 | 116.63% |
| Mar 31, 2021 | 2.13% |
| Dec 31, 2020 | 9.41% |
| Sep 30, 2020 | 76.54% |
| Jun 30, 2020 | 56.32% |
| Mar 31, 2020 | 56.30% |
| Dec 31, 2019 | 23.10% |
| Sep 30, 2019 | 1,598.41% |
| Dec 31, 2018 | 325.28% |
| Sep 30, 2018 | 49.82% |
| Dec 31, 2017 | -232.12% |
| Sep 30, 2017 | 5.77% |
| Jun 30, 2017 | 143.29% |
| Mar 31, 2017 | -11.47% |
| Dec 31, 2016 | -51.93% |
| Sep 30, 2016 | -12.69% |
| Jun 30, 2016 | 1.39% |
| Mar 31, 2016 | -24.51% |
| Dec 31, 2015 | -8.58% |
| Mar 31, 2015 | -7.81% |
| Mar 31, 2014 | 206.07% |
| Jun 30, 2013 | -2.12% |
| Mar 31, 2013 | 0.69% |
| Dec 31, 2012 | -3.74% |
| Sep 30, 2012 | -2.51% |
| Jun 30, 2012 | -2.71% |
| Mar 31, 2012 | -2.24% |
| Dec 31, 2011 | -3.32% |
| Sep 30, 2011 | -3.22% |